UNIONDALE, NY - ProPhase Labs, Inc. (NASDAQ:PRPH), currently trading at $0.39 and showing a -83% return over the past year, announced Monday it has entered an agreement for potential advisory services ...
UNIONDALE, NY - ProPhase Labs, Inc. (NASDAQ:PRPH), a microcap healthcare company with a market value of $18.69 million, announced Tuesday that its three COVID-19 testing laboratory subsidiaries have ...
UNIONDALE, NY, Sept. 23, 2025 (GLOBE NEWSWIRE) -- ProPhase Labs, Inc. (NASDAQ: PRPH) (“ProPhase” or the “Company”), a next generation biotech, genomics and consumer products company, announced that ...
(MENAFN- GlobeNewsWire - Nasdaq) UNIONDALE, NY, Sept. 22, 2025 (GLOBE NEWSWIRE) -- ProPhase Labs, Inc. (NASDAQ: PRPH) (“ProPhase” or the“Company”), a next ...
ProPhase Labs Inc. (Nasdaq: PRPH), a biotech firm with plans to build a crypto treasury, announced on Sep. 23 that its three COVID-19 testing lab units have filed for reorganization under Chapter 11 ...
ProPhase Labs (PRPH) entered into an agreement relating to potential advisory services. Management continues to evaluate a range of options for potential allocation of balance sheet resources, ...
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings.
Nketiah stoppage-time Palace winner gives Liverpool first league defeat At a glance Ismaila Sarr puts Palace ahead, Jean-Philippe Mateta hits post and Liverpool keeper Alisson makes several fine saves ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback